We can readily understand why investors are attracted to unprofitable companies. For example, Edgewise Therapeutics (NASDAQ:EWTX) shareholders have done very well over the last year, with the share ...

Approval has been given for the first UK launch of a traditional "vertical" rocket. The critical clearance from the air safety regulator has taken the country a step closer to seeing its first ...

The licence for a vertical launch is the final authorisation needed to realise Britain’s decade-long ambition to become an independent spacefaring nation with its own privately developed ...

Investors in Edgewise Therapeutics Inc (Symbol: EWTX) saw new options become available today, for the December 19th expiration. One of the key inputs that goes into the price an option buyer is ...

Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. PT (4:30 p.m. ET) - Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease ...

January 13, 2025--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming priorities for 2025. Edgewise Chief ...

--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming priorities for 2025.

Microsoft launched a new collaborative app called Loop in November 2023. However, it was basic at best in version 1.0 and left much to be desired for power users. After a year of updates and ...

If you'd asked us a year ago if we’d heard of Loop Earplugs, we wouldn’t have known what you meant. After all, a device which lets you control the loudness of your surroundings seems too good ...

On Friday, Evercore ISI initiated coverage on Edgewise Therapeutics (NASDAQ:EWTX) shares, a biopharmaceutical company, with an Outperform rating and a price target of ...